Tandem Diabetes Care TNDM
NASDAQ TNDM
$16.50 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tandem Diabetes Care (TNDM) Return on Sales [ROS] (2013 - 2026)

Updated

Tandem Diabetes Care's Return on Sales [ROS] came in at -5.42% for Q2 2026, up 16.11 percentage points from -21.53% a year earlier and up 1.63 percentage points from the prior quarter.

Analysis

Tandem Diabetes Care (TNDM) Return on Sales [ROS] (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Tandem Diabetes Care reported Return on Sales [ROS] of -4.40%, up 15.50 percentage points year-over-year; for FY2025, it came in at -18.45%, down 7.91 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of -16.86 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -10.54% in FY2024 (+20.65 pp), -31.19% in FY2023 (-19.60 pp), -11.59% in FY2022 (-14.81 pp) and 3.22% in FY2021 (+4.82 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -75.46% (Q1 2023) to 6.07% (Q4 2021).
  • Year-over-year, Return on Sales [ROS] has increased for four consecutive quarters, with an average year-over-year change of +6.45 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q1 2024 (a gain of 53.72 percentage points), and the weakest in Q1 2023 (a drop of 66.74 percentage points).
  • Business Quant data shows TNDM's Return on Sales [ROS] at -7.05% (Q1 2026), 2.86% (Q4 2025) and -9.17% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 Tandem Diabetes Care 1.15 Bn -490.62 Mn 144.78 Mn -5.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.42%
Mar 31, 2026 -7.05%
Dec 31, 2025 2.86%
Sep 30, 2025 -9.17%
Jun 30, 2025 -21.53%
Mar 31, 2025 -51.56%
Dec 31, 2024 -0.21%
Sep 30, 2024 -10.70%
Jun 30, 2024 -13.87%
Mar 31, 2024 -21.74%
Dec 31, 2023 -17.82%
Sep 30, 2023 -16.99%
Jun 30, 2023 -19.81%
Mar 31, 2023 -75.46%
Dec 31, 2022 -8.06%
Sep 30, 2022 -23.22%
Jun 30, 2022 -6.11%
Mar 31, 2022 -8.72%
Dec 31, 2021 6.07%
Sep 30, 2021 4.30%
API Access

Tandem Diabetes Care Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TNDM&period=max&api_key=YOUR_API_KEY